$BBNX 8-K SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Results of Operations and Financial Condition (Former name or former address, if changed since last report)
17 Sep 2026	8-K: Other Events IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) – Beta Bionics, Inc. (Nasdaq: BBNX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $125.0 million of share...
15 Sep 2026	8-K: Regulation FD Disclosure; Other Events Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this presentation that are not statements of historical fact are forward-looking s...
29 Jul 2026	8-K: Results of Operations and Financial Condition
22 May 2026	8-K: Submission of Matters to a Vote of Security Holders
21 May 2026	8-K: Regulation FD Disclosure; Other Events
21 Apr 2026	8-K: Results of Operations and Financial Condition
17 Feb 2026	8-K: Results of Operations and Financial Condition
30 Jan 2026	8-K: Other Events
08 Jan 2026	8-K: Results of Operations and Financial Condition
28 Oct 2025	8-K: Results of Operations and Financial Condition
29 Jul 2025	8-K: Results of Operations and Financial Condition
23 Jun 2025	8-K: Regulation FD Disclosure
06 May 2025	8-K: Results of Operations and Financial Condition
27 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation
25 Mar 2025	8-K: Results of Operations and Financial Condition
31 Jan 2025	8-K: Unregistered Sales of Equity Securities; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

Comments